Paul, M. Daikos, G.L. Durante-Mangoni, E. Yahav, D. Carmeli, Y. Benattar, Y.D. Skiada, A. Andini, R. Eliakim-Raz, N. Nutman, A. Zusman, O. Antoniadou, A. Pafundi, P.C. Adler, A. Dickstein, Y. Pavleas, I. Zampino, R. Daitch, V. Bitterman, R. Zayyad, H. Koppel, F. Levi, I. Babich, T. Friberg, L.E. Mouton, J.W. Theuretzbacher, U. Leibovici, L., Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial, The Lancet Infectious Diseases, (18), 391-400, 2018, The Lancet Publishing Group,